tirzepatide surmount-1 percent weight loss 72 weeks Adults with obesity using maintain 'remarkable' at 88 SURMOUNT-1 Trial - Cardionerds Twitter

However, indirect factorsincluding altered gastric emptying, reduced dietary intake, and concurrent metformin usemay influence B12 status in patients taking this medication

Additionally, the weight loss facilitated by Tirzepatide can lead to better glycemic control, lower blood pressure, and improved lipid profilesreducing the risk of obesity-related complications such as type 2 diabetes, hypertension, and dyslipidemia

Most importantly, find a workout you enjoy

Most are mild to moderate, hit hardest during dose escalation, and improve at stable doses

A large retrospective study found that patients who used phentermine continuously for more than 12 months maintained greater weight loss at 24 months (7.4% more than the referent group) without increased cardiovascular risk

This dual-action approach not only improves insulin sensitivity but also aids in weight loss